Stemcell Holdings IncOTC Pink - Limited Information:STMM
- LAST PRICE0.0600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0750/ 100
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0600
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Stemcell Holdings Inc | 1.6M | 750.0x | --- |
Globeimmune Inc | 10.0 | 0.0x | --- |
Petros Pharmaceuticals Inc | 3.4M | -0.1x | --- |
Athersys Inc | 60.0 | 0.0x | --- |
Stemtech Corp | 3.2M | -0.5x | --- |
International Stem Cell Corp | 800.4K | -1.5x | --- |
Company Information
Stemcell Holdings, Inc. is engaged in the regenerative medicine-related business, which provides technical assistance to the culturing, storing and delivery of stem cells, administrative and consulting services to clinics. The Company provides two options for stem cell regenerative therapy: autologous adipose derived mesenchymal stem cells (ADMSC) and natural killer cells (NK). The Company provides coordination services to facilitate its stem cell culturing business. Its coordination services include the introduction of patients to clinics, arranging patients’ schedules, and translating between patients and clinics. The Company offers Internet marketing services by providing search engine optimization for clinics. It also offers property and equipment rental services. The Company operates through its wholly owned subsidiary, Stemcell Co., Ltd.
Contact Information
- Headquarters
- Omotesando Helene Clinic 3-18-17-6FMINATO-KU, TKY, Japan 107-0062
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6M |
|---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 427.4M |
Stemcell Holdings Inc does not pay a dividend. | |
Beta | --- |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | 750.0x |
Price/Sales (TTM) | 0.2 |
Price/Cash Flow (TTM) | 0.5x |
Operating Margin | 48.03% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
